Cats tend to have a type of skin cancer in their heads and mouths that some researchers are using as a model for
human head and neck cancers.
Interestingly, Myh9 is also mutated in
human head and neck cancers, and low expression of myosin IIa correlates with poor prognosis for the patient,» says Fuchs.
Dr. Bauman and her colleagues treated
human head and neck cancer cells in the laboratory with varying doses of sulforaphane and a control, and compared them to normal, healthy cells that line the throat and mouth.
Not exact matches
Finally, a Calgary, Alberta — based company, Oncolytics Biotech, is testing a reovirus (an RNA virus often found in
human lungs but thought to be nonpathogenic) against several types of
cancer, including that of the lung
and skin as well as
head and neck malignancies.
In 2011 the National Toxicology Program at the Department of Health
and Human Services declared formaldehyde a known human carcinogen, demonstrated by human and animal studies to cause cancer of the nose, head, neck and lymphatic sy
Human Services declared formaldehyde a known
human carcinogen, demonstrated by human and animal studies to cause cancer of the nose, head, neck and lymphatic sy
human carcinogen, demonstrated by
human and animal studies to cause cancer of the nose, head, neck and lymphatic sy
human and animal studies to cause
cancer of the nose,
head,
neck and lymphatic system.
The results of the mouse,
human and lab studies have been so successful that Dr. Bauman has started a larger clinical trial in volunteers previously cured of
head and neck cancer.
Human papilloma virus (HPV), the culprit behind cervical
cancer and some forms of
head and neck cancer may hide in small pockets on the surface of tonsils in people not known to carry the virus.
Smokers, drinkers,
and people infected with the
human papillomavirus (HPV) have the highest risk of developing
head and neck cancer, which is the collective name for tumors found in the oral cavity, including the mouth, larynx,
and pharynx.
The first clinical trial with HB - 201 targeting
human papilloma virus - induced
head and neck cancer is currently being prepared.
We have completed the active phase of a Phase 1 trial of a Vaxwave ® - based vaccine against cytomegalovirus (CMV)
and are finalizing clinical development plans for TheraT ® in
Human Papilloma Virus (HPV)- related
head and neck cancers.
Tags: Adaptive Biotechnologies, Clinical Research, CMV, Colleen Delaney, Computational Biology, cytomegalovirus, Eddie Mendez, Harlan Robins,
head neck cancers,
Human Biology, Michael Boeckh, muscular dystrophy, Stephen J Tapscott, tumor paint, Vaccine
and Infectious Disease, VIDD
The study, by O'Donnell;
head and neck cancer specialists Everett E. Vokes, MD, physician - in - chief
and chair of the Department of Medicine,
and Ezra Cohen, MD;
and several investigators from the CPT team
and Department of
Human Genetics, was published in the May 2011 Translational Research.
Risk factors for
head and neck cancers include: tobacco use, heavy alcohol consumption, prolonged sun exposure,
and certain viruses, including
human papillomavirus (HPV)
and Epstein - Barr virus (EBV).
Human papilloma virus (HPV) infects the DNA of the skin or mucus membrane
and is known to cause
head and neck cancer, cervical
cancer,
and other forms.
Studies of Gluts in
human tumors have shown a significant increase in the abundance of Glut1
and Glut3 mRNA in
cancers of the esophagus, colon,
and pancreas, overexpression of Glut1
and Glut3 mRNA
and Glut1 protein expression in
head and neck tumors
and Glut1 protein overexpression in breast
and renal cell carcinomas
Like
cancer in
humans,
cancer in pets can be found in the bones, skin,
head, breast,
neck, testicles, abdomen
and lymph system,
and will likely spread throughout the body's organs in a similar manner to
human cancer.